Skip to main navigation Skip to main content
  • E-Submission
  • Contact us

NS : Neurospine

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

1
results for

"CRISPR"

Article category

Publication year

Keywords

Authors

Funded articles

"CRISPR"

Review Article

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

Include:

Advances in Therapeutic Applications of CRISPR Genome Editing for Spinal Pain Management
Neurospine. 2025;22(2):421-440.   Published online June 30, 2025
Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:
Include:
Advances in Therapeutic Applications of CRISPR Genome Editing for Spinal Pain Management
Neurospine. 2025;22(2):421-440.   Published online June 30, 2025
Close
Neuropathic pain remains a significant clinical challenge due to the limited efficacy and sustainability of existing pharmacological treatments, underscoring the urgent need for mechanism-based therapeutic strategies. In recent years, gene-targeted interventions have emerged as promising modalities capable of modulating key molecular pathways implicated in chronic pain. Approaches such as antisense oligonucleotides and RNA interference have demonstrated encouraging preclinical results by selectively downregulating pain-associated genes. Based on these developments, genome-editing technologies—particularly the clustered regularly interspaced short palindromic repeats (CRISPR) system—have enabled more precise and long-lasting modifications at both the DNA and RNA levels. This review highlights how CRISPR-based approaches in addressing the critical issues of specificity and long-term efficacy in pain gene therapy and exploring the functional roles of key gene targets and regulatory elements. Although challenges such as off-target activity and immunogenic responses remain, growing preclinical evidence supports the feasibility of CRISPR-based approaches in neuropathic pain. Collectively, these developments position CRISPR as a transformative tool to innovate the standard care for persistent pain syndromes and contribute to broader biomedical and pharmaceutical developments through continued refinement of targeting strategies and safety profiles.

Citations

Citations to this article as recorded by  Crossref logo
  • Targeting Nav Channels for Pain Relief: Structural Insights and Therapeutic Opportunities
    Yuzhen Xie, Xiaoshuang Huang, Fangzhou Lu, Jian Huang
    International Journal of Molecular Sciences.2026; 27(3): 1180.     CrossRef
  • Unraveling Chronic Pain: From Mechanisms and Risks to Diagnosis and Treatment
    Xiaofeng Dai, Chongxiang Wang, Ping Jiang, Xiaopeng Mei
    MedComm.2026;[Epub]     CrossRef
  • Neuroinflammation in stroke—A review of implications for precision immunomodulation
    Tatyana Zharikova, Elizaveta Petrova, Igor Makarov, Ulyana Preobrazhenskaya, André Pontes-Silva, Yury Zharikov
    Neuroscience.2026; 604: 2.     CrossRef
  • Pain Assessment
    Weibin Shi, Hong Wu, Jacob Benrud, Thiru M. Annaswamy
    Physical Medicine and Rehabilitation Clinics of North America.2026;[Epub]     CrossRef
  • Long non-coding RNAs as key modulators in neuropathic pain: mechanistic pathways and novel therapeutic opportunities
    Lingling Guo, Guangwei Sun, Lu Li, Guang Han
    Anesthesiology and Perioperative Science.2026;[Epub]     CrossRef
  • Advanced biomaterials and virtual reality for interventions in rare episodic cluster headache mimicking SUNCT syndrome: emerging directions in precision pain management
    Zeeshan Ahmed, Muneeb Saifullah, Maliha Khalid, Muhammad Talha, Aminath Waafira
    Annals of Medicine & Surgery.2025; 87(10): 6920.     CrossRef
  • Designing Neural Dynamics: From Digital Twin Modeling to Regeneration
    Calin Petru Tataru, Adrian Vasile Dumitru, Nicolaie Dobrin, Mugurel Petrinel Rădoi, Alexandru Vlad Ciurea, Octavian Munteanu, Luciana Valentina Munteanu
    International Journal of Molecular Sciences.2025; 27(1): 122.     CrossRef
  • 11,281 View
  • 135 Download
  • 7 Web of Science
  • 7 Crossref